Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
12781
Testisin is required for barrier function in HMEC-1 endothelial monolayers.
Published 2020“…Mean ± SEM. ***: p<0.001, **: p<0.01, *: p<0.05, ns: not significant.…”
-
12782
-
12783
Body weight development of male (upper curves) and female (lower curves) rats.
Published 2014“…Each data point represents mean ± SE (n = 5).</p>…”
-
12784
-
12785
-
12786
NADPH oxidation and H<sub>2</sub>O<sub>2</sub> production by Bs3 and Bs3<sub>S211A</sub>.
Published 2021“…<p>A) Buffer containing 100 μM NADPH was mixed with 0.2 μM Bs3 or Bs3<sub>S211A</sub> and incubated at 25°C. …”
-
12787
BMD analysis of serum free T4 (A), serum free T3 (B) and serum TSH (C) in males (triangles) and females (circles).
Published 2014“…Small symbols indicate individual samples, large symbols the group mean; the vertical dotted line indicates the dose (CED) with 5% decrease or increase (CES -0.05) compared to background (a parameter). …”
-
12788
BMD analysis of red cell count (A), hematocrit (B) and hemoglobin (C) in males (triangles) and females (circles).
Published 2014“…<p>These parameters were dose-dependently decreased in both genders. Small symbols indicate individual samples, large symbols the group mean; the vertical dotted line indicates the dose (CED) with 5% decrease (CES -0.05) compared to background (a parameter). …”
-
12789
Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12790
Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12791
Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12792
Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12793
Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12794
Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12795
Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12796
Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12797
Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12798
Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12799
Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
-
12800
Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF
Published 2019“…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”